Evidence map›Paper›PMID 33440629›Full record

ArticleFoods (Basel, Switzerland)2021

Steroid Glycosides Hyrcanoside and Deglucohyrcanoside: On Isolation, Structural Identification, and Anticancer Activity.

Silvie Rimpelová, Tomáš Zimmermann, Pavel B Drašar, Bohumil Dolenský, Jiří Bejček, Eva Kmoníčková, Petra Cihlářová, Soňa Gurská, Lucie Kuklíková, Marián Hajdůch and 4 more

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Frontiers in pharmacology · 2024
    Article
  3. Article
  4. Bioactive Compounds ofMolecules (Basel, Switzerland) · 2022
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Toxins · 2021
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Silvie RimpelováDepartment Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic.ORCID 0000-0002-3008-1396
Tomáš ZimmermannDepartment of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic.ORCID 0000-0003-0529-723X
Pavel B DrašarDepartment of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic.ORCID 0000-0003-0093-7007
Bohumil DolenskýDepartment of Analytical Chemistry, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic.
Jiří BejčekDepartment Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic.
Eva KmoníčkováDepartment of Pharmacology and Toxicology, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 76, 323 00 Pilsen, Czech Republic.
Petra CihlářováDepartment of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic.
Soňa GurskáInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital in Olomouc, Hněvotínská 976/3, 779 00 Olomouc, Czech Republic.
Lucie KuklíkováDepartment Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic.
Marián HajdůchInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital in Olomouc, Hněvotínská 976/3, 779 00 Olomouc, Czech Republic.
Tomáš RumlDepartment Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic.ORCID 0000-0002-5698-4366
Lubomír OpletalDepartment of Pharmaceutical Botany, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
Petr DžubákInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital in Olomouc, Hněvotínská 976/3, 779 00 Olomouc, Czech Republic.ORCID 0000-0002-3098-5969
Michal JurášekDepartment of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic.ORCID 0000-0002-5069-9716
University of Chemistry and Technology, Prague · CZInstitute of Molecular and Translational Medicine · CZCharles University · CZ

Funding

Grantová Agentura České Republiky 14-04329SMinisterstvo Školství, Mládeže a Tělovýchovy LM2018130Ministerstvo Školství, Mládeže a Tělovýchovy LM2018133
6 · The paper itself

Abstract

Cardiac glycosides (CGs) represent a group of sundry compounds of natural origin. Most CGs are potent inhibitors of Na

Indexed as

anticancer activitycardiac glycosidescymarindeglucohyrcanosidedigitoxinhyrcanosideNa+/K+-ATPase inhibitorsnatural product isolationouabainsecondary plant metabolites

Identifiers

PMID33440629
PMCPMC7827417
OpenAlexW3119940157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.